Patents Assigned to PURE GREEN PHARMACEUTICALS, INC.
  • Patent number: 11951086
    Abstract: A composition includes n-acyl ethanolamine, at least one cannabinoid, and at least one terpene. The composition may be in the form of a tablet.
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: April 9, 2024
    Assignee: PURE GREEN PHARMACEUTICALS, INC.
    Inventors: Debra Kimless, John S. Althaus, Stephen Goldner
  • Patent number: 10729734
    Abstract: A process includes rupturing plant cells of cannabis by freeze-drying the cannabis at a temperature below 0° C. in order to expose or release one or more chemicals including at least cannabinoids in the plant cells of the cannabis, after rupturing the cannabis plant cells, extracting the one or more chemicals including at least cannabinoids from the cannabis by pressurizing the cannabis in a pressure vessel with along with a solvent, the solvent dissolving the one or more chemicals including at least cannabinoids, followed by depressurizing the cannabis in the pressure vessel, where the depressurizing precipitates the one or more chemicals including at least cannabinoids out of the solvent, and then isolating the one or more chemicals including at least cannabinoids that precipitated from the solvent.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: August 4, 2020
    Assignee: PURE GREEN PHARMACEUTICALS, INC.
    Inventor: Stephen Goldner